Catheters are hollow, flexible tubes inserted into the body to administer fluids, drain urine from the bladder or other regions, administer medicine, and more. Antimicrobial catheters are coated with antimicrobial agents that prevent the formation of biofilms and inhibit microbial growth. The rising prevalence of hospital-acquired infections and technological advancements in antimicrobial coatings are fueling the demand for antimicrobial catheters.
The Global Antimicrobial Catheter Market Size is estimated to be valued at US$ 14505.18 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. The key players are focusing on new product launches and partnerships to expand their presence and address the unmet needs in antimicrobial catheter management. Technological advancements in antimicrobial coatings such as combination therapy using silver and antibiotics is expected to provide new growth opportunities in the market. Catheter associated urinary tract infections are one of the most common healthcare-associated infections. The increasing incidence of urinary tract infections is expected to drive the demand for antimicrobial catheters during the forecast period.
Market Drivers
The rising prevalence of hospital-acquired infections is a key driver propelling the growth of the antimicrobial catheter market. Catheter-associated urinary tract infections (CAUTIs) account for nearly 40% of all healthcare-associated infections in US hospitals. Antimicrobial catheters help prevent such infections and reduce healthcare costs associated with treatment. Furthermore, the growing geriatric population who are more prone to urinary disorders is also fueling the demand for antimicrobial catheters globally.
Current challenges in antimicrobial catheter market:
There are various challenges being faced by the antimicrobial catheter market currently. One of the major challenges is rising incidences of hospital acquired infections due to improper use and lack of hygiene during catheterization process. With covid-19 pandemic putting additional burden on healthcare systems, keeping infections under control has become even more crucial. Other challenges include high costs associated with antimicrobial coatings on catheters, risk of developing antibiotic resistance due to overuse of antimicrobial agents, and maintaining long term efficacy of coatings.
SWOT Analysis
Strength: Antimicrobial coatings help reduce risks of infections and associated healthcare costs. Wide applications in urology and critical care units.
Weakness: High pricing of coated catheters limits widespread adoption. Risk of toxicity due to leaching of agents cannot be eliminated.
Opportunity: Rising incidence of HAIs increases demand. Developing economies with improving healthcare infrastructures present new markets.
Threats: Stringent regulatory approvals delay market entry. Threat of substitute products like impregnated dressings and gels.
The United States accounts for the largest share in the antimicrobial catheter market currently due to large healthcare expenditure, growing elderly population prone to UTIs, and strong presence of manufacturers. Europe is another major region driven by rising cases of CAUTIs and implementation of strict hygiene guidelines in hospitals.
The Asia Pacific region is expected to register fastest growth during the forecast period owing to improving access to healthcare, increasing medical tourism, large patient pool, and rising government focus on preventing HAIs. Countries like China, India and Indonesia are emerging as high potential markets.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
